domingo, 30 de noviembre de 2025

Does Screening Interval Matter? Annual Mammograms Tied to Better Survival in Breast Cancer Maurie Markman, MD ++++++ +++ +++

Trending in November Proton vs Photon RT in Breast Cancer: Which Is Better? https://www.medscape.com/viewarticle/proton-vs-photon-rt-breast-cancer-which-better-2025a1000v0g?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 Annual Screening Boosts Breast Cancer Survival https://www.medscape.com/viewarticle/does-screening-interval-matter-annual-mammograms-tied-better-2025a1000sgu?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 Routine Liquid Biopsies Could Cut Advanced Cancer Diagnoses https://www.medscape.com/viewarticle/routine-liquid-biopsies-could-cut-advanced-cancer-diagnoses-2025a1000vsm?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 Rediscovering Purpose in the Hardest Moments of Cancer Care https://www.medscape.com/viewarticle/rediscovering-purpose-hardest-moments-cancer-care-2025a1000tt1?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 How to Identify Cancer in Patients With Nonspecific Symptoms https://www.medscape.com/viewarticle/how-identify-cancer-patients-nonspecific-symptoms-2025a1000vn0?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 The Cancer Misinformation Train: When Influencers Co-Opt Care https://www.medscape.com/viewarticle/cancer-misinformation-train-when-influencers-co-opt-care-2025a1000utj?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 Also of Interest Rethinking Ribociclib: Is 400 mg Noninferior to 600 mg for MBC? https://www.medscape.com/viewarticle/rethinking-ribociclib-400-mg-noninferior-600-mg-metastatic-2025a1000tt2?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 Novel Agents Transform Double-Refractory CLL Care https://www.medscape.com/viewarticle/novel-agents-transform-double-refractory-chronic-lymphocytic-2025a1000jhf?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 Is This Drug Combo the Future of CLL? https://www.medscape.com/viewarticle/this-drug-combo-future-chronic-lymphocytic-leukemia-care-2025a1000rdh?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 US Drug Spotlight Capivasertib https://reference.medscape.com/drug/truqap-capivasertib-4000384?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 Rituximab https://reference.medscape.com/drug/rituxan-truxima-rituximab-342243?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865 Acalabrutinib https://reference.medscape.com/drug/calquence-acalabrutinib-1000209?ecd=mkm_ret_251130_mscpmrk_onc_top-content_etid7912865&uac=148436CN&impID=7912865

No hay comentarios:

Publicar un comentario